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Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine) is  an anticonvulsant drug used in 
the treatment of epilepsy and bipolar disorder, chemically unrelated to any currently marketed 
antiepileptic drugs. It is extensively metabolized in humans to produce predominantly the N2-
glucuronide and to a minor extent the N2-methyl-lamotrigine. The N2-methylated metabolite has 
been found to have cardio-active properties. The metabolism of lamotrigine in rats, apart from 
other metabolites, yields N2-oxide-lamotrigine. Since most pharmaceuticals used in human 
medicine are eventually disposed of with the sewage, wastewater treatment facilities play a key 
role in removing drugs from the waste stream, thus preventing them from reaching the receiving 
water bodies. Recently, a U.S. study revealed the environmental occurrence of lamotrigine and its 
N2-glucuronide with mean concentrations in wastewater of 488 and 209 ng/L, respectively. 
However, they did not monitor transformation products of lamotrigine that can potentially be 
generated during the biological wastewater treatment.
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Background Experimental section
This study describes the assessment of the biodegradation of the lamotrigine, an anticonvulsant drug,   by the bacterial community in mixed liquor from  a municipal STP. The UPLC 
analysis of the samples from the aerated batch-reactor loaded with undiluted mixed liquor showed the formation of a single metabolite. High resolution mass spectrometry (QToF)
pointed towards conversion of lamotrigine through a methylation pathway. In on-going studies we are currently investigating whether this microbial transformation product is chemically 
identical to the N2-methylated metabolite formed in humans.
Detection of transformtion products of environmental contaminants in the environmental matrices is a challenging task because not only are they present in very low concentrations but 
they are also mixed with complex matrices that interfere with the detection. Therefore, Orbitrap mass spectrometry was used in a monitoring survey of lamotrigine, its metabolites and 
the identified TP of the present work. In the surface waters from the river Rhine (Basel, Switzerland) and in effluent samples of Swiss WWTPs that discharge into this river, lamotrigine 
was detected along with its human metabolites and the proposed methylated TP.
(+)ESI-MS/MS spectra of lamotrigine and its transformation product at ce 30 eV
Detection of lamotrigine, its metabolites and its TP in wastewater and surface waters in Swiss waters
Structural elucidation: UPLC-ESI (+)-QqToF-MS
Waters ACQUITY BEH C18 column (50 × 2.1 mm, 1.7 m). 
The mobile phases were (A) 0.1 % HCOOH and (B) 
acetonitrile.
Batch-reactors spiked with lamotrigine at concentrations of 10 mg L-1 
Sample preservation with 5% formaldehyde, storage at 
4 °C; In NAS the pH was maintained above 7.0 using 











































































 River Rhine in Basel – low fraction of treated waste water, large river 
m/z

















































Environmental measurements: LC-ESI (+)-LTQ-Orbitrap
Waters XBridge C18 column (50 × 2.1 mm, 3.5 m). The 
mobile phases were (A) 0.1 % HCOOH and (B) methanol.
Full scan MS (R 60’000; accuracy 5ppm) and data-
dependent MS/MS (R 7’500; 5ppm)  with sequential HCD 
and CID fragmentation





• Removal of parent pharmaceuticals in WWTPs does not mean complete elimination from wastewater effluents
• New TPs can be formed;  in our case the identified structure of the TP matches with the structure of a human metabolite of lamotrigine
• One human metabolite and one TP were detected in the surface waters from the river Rhine (Basel, Switzerland) and in effluent samples of Swiss WWTPs that discharge into this river
